552 related articles for article (PubMed ID: 33958804)
21. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
Huang Y
Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
[TBL] [Abstract][Full Text] [Related]
22. Tau, neurodegeneration and Alzheimer's disease.
Del Carmen Alonso A
Curr Alzheimer Res; 2010 Dec; 7(8):653-5. PubMed ID: 21214513
[No Abstract] [Full Text] [Related]
23. Propagation of tau pathology in a model of early Alzheimer's disease.
de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
[TBL] [Abstract][Full Text] [Related]
24. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
25. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus.
Dubelaar EJ; Verwer RW; Hofman MA; Van Heerikhuize JJ; Ravid R; Swaab DE
J Neuropathol Exp Neurol; 2004 Feb; 63(2):159-69. PubMed ID: 14989602
[TBL] [Abstract][Full Text] [Related]
26. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M
J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485
[TBL] [Abstract][Full Text] [Related]
27. The role of APOE in transgenic mouse models of AD.
Balu D; Karstens AJ; Loukenas E; Maldonado Weng J; York JM; Valencia-Olvera AC; LaDu MJ
Neurosci Lett; 2019 Aug; 707():134285. PubMed ID: 31150730
[TBL] [Abstract][Full Text] [Related]
28. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
[TBL] [Abstract][Full Text] [Related]
29. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I; Zou K; Esposito L; Bard F; Berber E; Can JV; Lin AH; Crews L; Tremblay P; Mathews P; Mucke L; Masliah E; Wyss-Coray T
J Clin Invest; 2006 Nov; 116(11):3060-9. PubMed ID: 17080199
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
Holtzman DM; Bales KR; Tenkova T; Fagan AM; Parsadanian M; Sartorius LJ; Mackey B; Olney J; McKeel D; Wozniak D; Paul SM
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2892-7. PubMed ID: 10694577
[TBL] [Abstract][Full Text] [Related]
31. ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum.
Belinson H; Michaelson DM
J Neural Transm (Vienna); 2009 Nov; 116(11):1427-34. PubMed ID: 19370389
[TBL] [Abstract][Full Text] [Related]
32. Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease?
Zhang Z; Na H; Gan Q; Tao Q; Alekseyev Y; Hu J; Yan Z; Yang JB; Tian H; Zhu S; Li Q; Rajab IM; Blusztajn JK; Wolozin B; Emili A; Zhang X; Stein T; Potempa LA; Qiu WQ
Aging Cell; 2021 Nov; 20(11):e13501. PubMed ID: 34687487
[TBL] [Abstract][Full Text] [Related]
33. Specific regional transcription of apolipoprotein E in human brain neurons.
Xu PT; Gilbert JR; Qiu HL; Ervin J; Rothrock-Christian TR; Hulette C; Schmechel DE
Am J Pathol; 1999 Feb; 154(2):601-11. PubMed ID: 10027417
[TBL] [Abstract][Full Text] [Related]
34. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.
Tesseur I; Van Dorpe J; Spittaels K; Van den Haute C; Moechars D; Van Leuven F
Am J Pathol; 2000 Mar; 156(3):951-64. PubMed ID: 10702411
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.
Litvinchuk A; Suh JH; Guo JL; Lin K; Davis SS; Bien-Ly N; Tycksen E; Tabor GT; Remolina Serrano J; Manis M; Bao X; Lee C; Bosch M; Perez EJ; Yuede CM; Cashikar AG; Ulrich JD; Di Paolo G; Holtzman DM
Neuron; 2024 Feb; 112(3):384-403.e8. PubMed ID: 37995685
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
Lewandowski CT; Maldonado Weng J; LaDu MJ
Neurobiol Dis; 2020 Jun; 139():104811. PubMed ID: 32087290
[TBL] [Abstract][Full Text] [Related]
37. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
[TBL] [Abstract][Full Text] [Related]
38. Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer's Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement.
Chen YC; Chiu YJ; Lin CH; Hsu WC; Wu JL; Huang CH; Lin CW; Yao CF; Huang HJ; Lo YS; Chen CM; Wu YR; Chang KH; Lee-Chen GJ; Mei Hsieh-Li H
J Alzheimers Dis; 2019; 67(2):737-756. PubMed ID: 30689566
[TBL] [Abstract][Full Text] [Related]
39. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
40. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
